Brief: Achilles Therapeutics Reports First Quarter 2022 Financial Results And Recent Business Highlights
May 10 (Reuters) - Achilles Therapeutics PLC 698y.F :
* ACHILLES THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* CASH BALANCE OF $237 MILLION SUPPORTS ALL PLANNED
OPERATIONS
INTO 2H 2024
* QTRLY NET LOSS PER SHARE ATTRIBUTABLE $0.45
* Q1 EARNINGS PER SHARE VIEW $-0.51 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8NHSMv
Further company coverage: 698Y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement